Ganirelix acetate injection is used for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation.
Sucralfate Oral Suspension had a market value of $188.5 million, of which $157.9 million represents generic sales, for the 12 months ending December 2021, according to IQVIA.
Retail pharmacy is up to the challenge of meeting consumers’ evolving needs and has proven over time that it has the edge over the efficiencies of e-commerce alternatives.
